Completing data — refresh the page later to see the latest
1202-04-6COC(=O)c1cc2ccccc2[nH]1NQPIEWBAWBFGOB-UHFFFAOYSA-N1202-04-6DTXSID10152726CHEMBL4467578Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 6 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesMethyl Indole-2-carboxylate has been shown to inhibit the production of β-amyloid, an important factor in the pathogenesis of Alzheimer's disease. Methyl indole-2-carboxylate has also been shown to inhibit ion exchange, melatonin synthesis and aziridine production. Methyl indole-2-carboxylate was found to have a very high affinity for aldehydes. It is also able to cross the blood-brain barrier into the brain and has been shown to be effective against pancreatic cancer cells in vitro.